Categories: HealthPhilippines

Surprisingly, AstraZeneca Withdraw it’s Schedule to Philippines

One of the options Philippines have just updates the country on it’s withdrawal schedule for vaccine. In view of this, the Food and Drug Administration has shared that AstraZeneca cancelled from conducting trials for its coronavirus vaccine candidate.

The local regulators were advised by the British-Swedish drugmaker that they already had enough evidence, which is why they will no longer go ahead with the trials. The FDA Director General Eric Domingo clearly update the changes about this. He clarify that the withdrawal of AstraZeneca to perform clinical trials for its coronavirus vaccine would have no effect on the shot’s regulatory approval.

AstraZeneca’s COVID-19 vaccine was infact on the process before the ethics review board before pulling out of performing trials. In view of this, The Philippines will be left with studies performed by Sinovac Biotech Ltd., Sichuan Clover Biopharmaceuticals, Gamaleya Research Center, and Johnson and Johnson’s vaccine arm Janssen with the departure of AstraZeneca from the conduct of clinical trials

But there’s something interesting since the support of some 30 private companies that pitched in to donate the shots to the government, the Philippines secured 2.6 million doses of the still-unapproved AstraZeneca vaccine.

One of them is Carlito Galvez, the country’s vaccine czar, previously expressed trust in the drugmaker’s development of the jab, citing its reputation for producing quality drugs and vaccines that are used worldwide.

However, AstraZeneca and its affiliate, the University of Oxford, have updated that they are pursuing regulatory approval for their vaccine in the United Kingdom after showing an overall efficacy rate of 70%.

When an initial half-dose then a full dose was given, the rate jumped to 90 percent, comparable to that in rival vaccines by Pfizer/BioNTech and Moderna in growth. Morever, the US scientists, however, point out that the higher efficacy rate came in a smaller trial consisting of individuals aged 55 and that makes them conduct studies even more.

Jasmine C.

Mabuhay! An upcoming Newswriter for the Asian Affairs from the Pearl of the Orient - Philippines. Avid follower of celebrity gossips, fashion news. I got into writing so that my fellow Kababayan will be constantly updated with the latest news.

Recent Posts

V Surprises ARMY with Two Holiday Releases: A Festive Collab with Park Hyo-shin and “White Christmas” Cover

For K-pop fans, the Christmas season this year has become even more magical as several of their preferred stars reveal…

November 22, 2024

Celine Names TWS as Global Ambassadors Following Suzy Bae Announcement

After Suzy Bae's nomination as Celine's worldwide ambassador, the venerable French luxury fashion company has taken another bold step choosing…

November 22, 2024

Reddit Faces Widespread Outage, Users Turn to Workarounds Amid ‘Server Error’ Messages

Thousands of users of the well-known social network Reddit were left without access after a major outage of the website.…

November 22, 2024

Anne Hathaway Casted as ‘Verity’ in Colleen Hoover’s Book Adaptation

Anne Hathaway is slated to play the much expected film version of Colleen Hoover's best-selling book Verity in front of…

November 21, 2024

Gucci Set to Revolutionize Fashion Presentations with Unified Shows in 2025 under Sabato De Sarno’s Vision

Gucci is ready to change its presentation approach for 2025 in a radical action aimed to revolutionize the fashion industry.…

November 21, 2024

South Korea’s “Korea Discount”: Addressing the Governance Gap to Boost Market Value

As world investors wait for significant changes that might solve long-standing problems of governance and responsibility in South Korea's companies,…

November 21, 2024

This website uses cookies.

Read More